Tarsons Products Past Earnings Performance
Past criteria checks 1/6
Tarsons Products's earnings have been declining at an average annual rate of -10.3%, while the Life Sciences industry saw earnings growing at 25.3% annually. Revenues have been growing at an average rate of 3.1% per year. Tarsons Products's return on equity is 5.6%, and it has net margins of 9.8%.
Key information
-10.3%
Earnings growth rate
-11.3%
EPS growth rate
| Life Sciences Industry Growth | 11.2% |
| Revenue growth rate | 3.1% |
| Return on equity | 5.6% |
| Net Margin | 9.8% |
| Next Earnings Update | 14 Feb 2025 |
Recent past performance updates
Recent updates
Tarsons Products Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 18
Tarsons Products Limited's (NSE:TARSONS) Popularity With Investors Is Clear
Jul 30Revenue Miss: Tarsons Products Limited Fell 7.8% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 18Tarsons Products Limited (NSE:TARSONS) Analysts Are More Bearish Than They Used To Be
Nov 22Tarsons Products Limited (NSE:TARSONS) Analysts Are More Bearish Than They Used To Be
Aug 17Analysts Have Lowered Expectations For Tarsons Products Limited (NSE:TARSONS) After Its Latest Results
Nov 10Tarsons Products Limited's (NSE:TARSONS) 26% Price Boost Is Out Of Tune With Earnings
Jul 20Tarsons Products Limited (NSE:TARSONS) Shares Could Be 28% Below Their Intrinsic Value Estimate
Jul 05Tarsons Products' (NSE:TARSONS) Promising Earnings May Rest On Soft Foundations
Jun 04Revenue & Expenses Breakdown
How Tarsons Products makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3,516 | 345 | 622 | 0 |
| 30 Jun 24 | 3,186 | 371 | 512 | 0 |
| 31 Mar 24 | 2,964 | 426 | 489 | 0 |
| 31 Dec 23 | 2,727 | 551 | 423 | 0 |
| 30 Sep 23 | 2,723 | 613 | 409 | 0 |
| 30 Jun 23 | 2,772 | 700 | 399 | 0 |
| 31 Mar 23 | 2,832 | 807 | 391 | 0 |
| 31 Dec 22 | 2,887 | 874 | 365 | 0 |
| 30 Sep 22 | 2,981 | 927 | 356 | 0 |
| 30 Jun 22 | 3,029 | 961 | 345 | 0 |
| 31 Mar 22 | 3,008 | 1,007 | 338 | 0 |
| 31 Dec 21 | 2,858 | 948 | 314 | 0 |
| 30 Jun 21 | 2,581 | 867 | 286 | 0 |
| 31 Mar 21 | 2,313 | 689 | 267 | 0 |
| 31 Mar 20 | 1,750 | 385 | 206 | 0 |
| 31 Mar 19 | 1,886 | 399 | 164 | 0 |
Quality Earnings: TARSONS has high quality earnings.
Growing Profit Margin: TARSONS's current net profit margins (9.8%) are lower than last year (22.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TARSONS's earnings have declined by 10.3% per year over the past 5 years.
Accelerating Growth: TARSONS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: TARSONS had negative earnings growth (-43.7%) over the past year, making it difficult to compare to the Life Sciences industry average (38.1%).
Return on Equity
High ROE: TARSONS's Return on Equity (5.6%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/31 23:52 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Tarsons Products Limited is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nitin Bhasin | Ambit Capital |
| Karan Khanna | Ambit Capital |
| Vijayaraghavan Swaminathan | Avendus Spark |